|
1
|
Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents.
|
Cancer Chemother Pharmacol
|
2009
|
1.12
|
|
2
|
Absorption and intestinal metabolism of SDZ-RAD and rapamycin in rats.
|
Drug Metab Dispos
|
1999
|
0.98
|
|
3
|
Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125.
|
J Pharmacokinet Biopharm
|
1994
|
0.89
|
|
4
|
Effect of the Mdr1a P-glycoprotein gene disruption on the tissue distribution of SDZ PSC 833, a multidrug resistance-reversing agent, in mice.
|
J Pharmacol Exp Ther
|
1998
|
0.81
|
|
5
|
Dose-dependent brain penetration of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin, in rats.
|
Cancer Chemother Pharmacol
|
1996
|
0.76
|
|
6
|
Microdialysis sampling to determine the pharmacokinetics of unbound SDZ ICM 567 in blood and brain in awake, freely-moving rats.
|
Pharm Res
|
1995
|
0.75
|